News

A bacterial protein fragment instigates lung tissue death in the respiratory disease pulmonary fibrosis, according to a new study.

Contaminants that occur together naturally in groundwater under certain geological conditions may heighten health risks for millions whose drinking water comes from private wells, and current safety regulations don't address the problem.

Ultra-sensitive crumpled graphene biosensors could usher in an era of liquid biopsy, detecting DNA cancer markers circulating in a patient's blood or serum.

A new modelling study conducted in a simulated Singapore setting has estimated that a combined approach of physical distancing interventions, comprising quarantine (for infected individuals and their families), school closure, and workplace distancing, is most effective at reducing the number of SARS-CoV-2 cases compared with other intervention scenarios included in the study.

Old human cells can return to a more youthful state after being induced to briefly express a panel of proteins involved in embryonic development, according to a new study.

Canadian Prime Minister Justin Trudeau has announced that the University of Saskatchewan's Vaccine and Infectious Disease Organization – International Vaccine Centre VIDO-InterVac will receive $12 million to help address Canada’s shortage of vaccine manufacturing capacity.

Participant recruitment has begun for a Phase II clinical trial to investigate the safety and efficacy of treating adult patients with COVID-19 with remdesivir.

During the first global regulatory workshop, delegates from 17 countries, representing more than 20 medicines regulatory authorities globally, and experts from the WHO and the European Commission discussed regulatory considerations related to the development of SARS-CoV-2 vaccine candidates and preclinical data required to support proceeding to first-in-human (FIH) clinical trials.

A team of engineers from Penn State University may have found a way to predict which mutations will occur in people, creating an easier path to create effective pharmaceuticals.

A new study published in Nucleic Acid Research outlines the discovery that squid are able to "edit" their messenger RNA (mRNA) to an astonishing degree – several orders of magnitude more than humans.